Valbiotis SA (EPA:ALVAL)
France · Delayed Price · Currency is EUR 0.7660
+0.0110 (1.46%)
Aug 4, 2026, 5:35 PM CET
Valbiotis Revenue
In the year 2025, Valbiotis had annual revenue of 1.05M EUR, down -77.48%. Valbiotis had revenue of 660.00K in the half year ending December 31, 2025, a decrease of -58.04%.
Revenue
1.05M
Revenue Growth
-77.48%
P/S Ratio
20.02
Revenue / Employee
18.10K
Employees
50
Market Cap
18.12M
| Fiscal Year End | Revenue | Change | Growth |
|---|---|---|---|
| Dec 31, 2025 | 1.05M | -3.60M | -77.48% |
| Dec 31, 2024 | 4.64M | -2.17M | -31.80% |
| Dec 31, 2023 | 6.81M | 4.00M | 141.97% |
| Dec 31, 2022 | 2.81M | 121.00K | 4.49% |
| Dec 31, 2021 | 2.69M | -2.41M | -47.19% |
| Dec 31, 2020 | 5.10M | 3.19M | 166.54% |
| Dec 31, 2019 | 1.91M | 404.00K | 26.77% |
| Dec 31, 2018 | 1.51M | 727.00K | 92.97% |
| Dec 31, 2017 | 782.00K | 136.00K | 21.05% |
| Dec 31, 2016 | 646.00K | - | - |
Revenue Definition
Revenue, also called sales, is the amount of money a company receives from its business activities, such as sales of products or services. Revenue does not take any expenses into account and is therefore different from profits.
Related Stocks
| Company Name | Revenue |
|---|---|
| Danone | 27.48B |
| Savencia | 6.96B |
| Bonduelle SCA | 2.20B |
| Fleury Michon | 836.40M |
| Saint Jean Groupe Société anonyme | 119.68M |
| Sapmer | 93.90M |
| PAULIC Meunerie | 18.32M |
| Rapid Nutrition | 110.40K |
Valbiotis News
- 5 months ago - Valbiotis Earnings release: H2 2025 - Filings
- 5 months ago - Valbiotis Annual report: H2 2025 - Filings
- 9 months ago - Valbiotis Slides: Investor presentation - Filings
- 10 months ago - Valbiotis Quarterly report: H1 2025 - Filings